SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-046761
Filing Date
2010-03-03
Accepted
2010-03-03 14:40:55
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1461094
2 AMENDMENT TO DISCOVERY COLLABORATION AGREEMENT dex10361.htm EX-10.361 17625
3 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 5425
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-GRANT THORNTON LLP dex231.htm EX-23.1 1717
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-BDO SEIDMAN, LLP dex232.htm EX-23.2 1956
6 CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 6878
7 CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 6876
8 CERTIFICATION OF BY PRINCIPAL EXECUTIVE OFFICER - SECTION 906 dex321.htm EX-32.1 4321
9 CERTIFICATION OF BY PRINCIPAL FINANCIAL OFFICER - SECTION 906 dex322.htm EX-32.2 4323
10 GRAPHIC g75169g57z91.jpg GRAPHIC 51274
  Complete submission text file 0001193125-10-046761.txt   1582423
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 10653003
SIC: 2834 Pharmaceutical Preparations